These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431 [TBL] [Abstract][Full Text] [Related]
8. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485 [TBL] [Abstract][Full Text] [Related]
9. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis]. Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289 [TBL] [Abstract][Full Text] [Related]
10. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
11. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD. Kandoussi A; Cachera C; Pagniez D; Dracon M; Fruchart JC; Tacquet A Kidney Int; 1992 Aug; 42(2):424-5. PubMed ID: 1405325 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198 [TBL] [Abstract][Full Text] [Related]
13. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis. Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391 [TBL] [Abstract][Full Text] [Related]
15. [Expression of receptors for advanced glycation end products at surface of peripheral blood monocytes and relationship thereof to plasma proinflammatory cytokines in patients undergoing hemodialysis]. Ren H; Hou F; Bi Y; Zhang X Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1168-72. PubMed ID: 12475402 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis. Irish AB Metabolism; 1997 Jan; 46(1):36-40. PubMed ID: 9005966 [TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure. Ebihara I; Nakamura T; Tomino Y; Shimada N; Koide H Am J Nephrol; 1998; 18(4):305-10. PubMed ID: 9653834 [TBL] [Abstract][Full Text] [Related]
19. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis]. Zwolińska D; Szprynger K Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806 [TBL] [Abstract][Full Text] [Related]
20. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis. Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]